M&A activity underlines increased investment in active and biofunctional ingredients
Ashland today confirmed the acquisition of the Zeta Fraction biofunctional technology from rival ingredients player Akzo Nobel, a move that forms part of an industry-wide investment in advanced ingredients technology that has also included big players...